A thorough understanding of Onco-Cardiology, also known as cardio-oncology, is required for effective cancer treatment. Cardiotoxicity is associated with nearly all antineoplastic agents. To optimize treatment all patients being considered for chemotherapy, particularly those with a history of cardiac disease, should undergo a thorough cardiovascular evaluation. Serial testing of left ventricular systolic function and cardiac biomarkers may also be considered in certain patient populations.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
